BUSINESS● LOWSep 18 · Sep 18, 2026, 2:56 AM
Jazz Pharmaceuticals (JAZZ) Places An $820M Epilepsy Bet
Yahoo Finance · global
Jazz Pharmaceuticals (JAZZ) is making a substantial $820 million investment related to epilepsy. This highlights a significant strategic move by a major pharmaceutical company.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS53m agoForeign banks trim China branch networks as low returns test strategySouth China Morning PostBUSINESS1h ago‘Hot economics, cold politics’: why China gave nod for expanded Japanese trade tripSouth China Morning Post